← Scroll for more →
Financial Statements — DCBO
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 74.04 | 91.87 | 92.54 | 82.03 | 80.65 | 71.95 | 170.65 | 215.83 | 216.29 | 212.73 | 211.98 | 215.32 | 215.51 | 217.38 |
| Total Current Assets | 151.52 | 161.77 | 154.24 | 140.82 | 140.91 | 127.15 | 224.66 | 274.97 | 263.58 | 252.22 | 254.62 | 251.49 | -- | -- |
| Goodwill | 14.54 | 14.05 | 13.85 | 14.32 | 14.05 | 14.25 | 9.86 | 6.06 | 5.98 | 5.52 | 6.27 | 5.30 | -- | -- |
| Total Non-current Assets* | 55.12 | 35.91 | 36.47 | 33.32 | 32.17 | 31.22 | 29.51 | 20.18 | 20.08 | 18.45 | 18.90 | 16.63 | -- | -- |
| Total Assets | 206.65 | 197.67 | 190.71 | 174.14 | 173.08 | 158.38 | 254.18 | 295.15 | 283.67 | 270.67 | 273.52 | 268.12 | -- | -- |
| Total Current Liabilities | 123.80 | 140.57 | 128.60 | 124.85 | 108.39 | 100.65 | 110.83 | 92.88 | 84.36 | 75.00 | 76.99 | 69.17 | -- | -- |
| Total Non-current Liabilities* | 8.76 | 4.67 | 4.35 | 4.23 | 5.05 | 7.00 | 7.65 | 7.03 | 7.10 | 7.18 | 8.20 | 8.29 | -- | -- |
| Total Liabilities | 132.56 | 145.24 | 132.95 | 129.08 | 113.43 | 107.65 | 118.48 | 99.91 | 91.46 | 82.18 | 85.19 | 77.47 | -- | -- |
| Retained Earnings | (184.04) | (208.78) | (205.37) | (217.04) | (199.62) | (204.79) | (128.60) | (73.62) | (74.87) | (76.47) | (88.85) | (81.89) | -- | -- |
| Total Stockholder Equity | 74.09 | 52.43 | 57.76 | 45.06 | 59.64 | 50.72 | 135.70 | 195.25 | 192.21 | 188.49 | 188.33 | 190.66 | 191.00 | 197.26 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 57.30 | 55.43 | 51.40 | 46.51 | 43.59 | 41.46 | 36.97 | 34.94 | 32.06 | 27.07 | 25.63 | 21.74 |
| Cost of Revenue* | 11.40 | 10.46 | 9.93 | 8.78 | 8.41 | 8.05 | 7.14 | 6.98 | 6.55 | 5.68 | 5.15 | 3.86 |
| Gross Profit | 45.90 | 44.97 | 41.48 | 37.73 | 35.18 | 33.41 | 29.83 | 27.96 | 25.50 | 21.39 | 20.48 | 17.88 |
| Research & Development | 13.40 | 11.15 | 10.41 | 10.27 | 8.81 | 7.38 | 6.11 | 6.11 | 6.19 | 5.48 | 5.23 | 4.14 |
| Selling, General & Admin | 8.73 | 8.38 | 8.15 | 8.32 | 9.35 | 7.56 | 7.82 | 7.60 | 7.38 | 6.82 | 6.92 | 7.44 |
| Total Operating Expenses | 44.19 | 40.25 | 37.25 | 34.62 | 42.71 | 33.78 | 20.80 | 25.85 | 32.37 | 19.92 | 26.82 | 23.50 |
| Operating Income | 1.71 | 4.72 | 4.23 | 3.11 | (7.52) | (0.38) | 9.02 | 2.11 | (6.87) | 1.46 | (6.34) | (5.62) |
| Pretax Income | 2.36 | 5.34 | 4.77 | 5.04 | (5.12) | 1.61 | 10.37 | 2.46 | (6.83) | 1.46 | (6.40) | (5.60) |
| Tax Provision | 0.88 | 0.38 | (0.40) | 1.00 | 0.56 | 0.36 | 0.10 | 0.36 | 0.13 | 0.80 | 0.79 | 0.04 |
| Net Income | 1.47 | 4.96 | 5.17 | 4.05 | (5.67) | 1.25 | 10.27 | 2.10 | (6.96) | 0.66 | (7.19) | (5.64) |
| Basic EPS | 0.05 | 0.16 | 0.17 | 0.12 | (0.17) | 0.04 | 0.31 | 0.06 | (0.21) | 0.02 | (0.22) | (0.17) |
| Diluted EPS | 0.05 | 0.16 | 0.17 | 0.12 | (0.17) | 0.04 | 0.30 | 0.06 | (0.21) | 0.02 | (0.22) | (0.17) |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 7.95 | 8.43 | (2.18) | (1.97) | (2.18) |
| Investing Cash Flow | (0.30) | (0.20) | (0.11) | (1.37) | (0.17) |
| Financing Cash Flow | (8.80) | 0.52 | 1.70 | 0.10 | (0.10) |
← Scroll for more columns →